Lilly To Begin Posting All Phase II-IV Trials To ClinicalTrials.gov
This article was originally published in The Pink Sheet Daily
Executive Summary
The company is moving beyond the FDAMA requirements that only studies for serious or life-threatening diseases be included on the government-run database. Lilly will begin posting all new trials effective July 1; information for ongoing studies will be posted by Sept. 13.